“The premise of navigation systems is to provide accurate needle guidance for complex approaches with minimal disruption to our current workflow and the ActiViews system is designed specifically for this,“ commented Dr. Flacke. “The staff and I were extremely happy with the ease and simplicity of our first case, and we are looking forward to additional upcoming procedures.”
CT-Guide™ navigation is designed to assist physicians during CT-guided interventional diagnostic and therapeutic procedures such as percutaneous biopsies, ablations, and marker placements in the lung and liver. The system enables physicians to locate interventional instruments in relation to pre-acquired CT images, which is analogous to the way a GPS locates a car using stored roadmaps. CT-Guide™ navigation allows physicians to determine the location of the navigated instrument in relation to the 3D space of the CT images and the desired target, continuously displaying the location of the instrument and its planned path on the CT image of the patient’s anatomy.
“This is a significant milestone for ActiViews since to-date our over 1,000 cases performed with CT-Guide™ navigation have been outside the U.S.,” commented Christopher von Jako, President of ActiViews, Inc. “Following our two successful FDA clearances in the last six months, we are excited to begin doing procedures at selected U.S. hospitals before our official commercialization launch. Due to the collaborative and innovative nature of the physicians, the Lahey Clinic was a perfect institution to begin our U.S. efforts.”
The Lahey Clinic, a physician-led, nonprofit group practice, is world-renowned for innovative technology, pioneering medical treatment, and leading-edge research. A teaching hospital of Tufts University School of Medicine, the Lahey Clinic provides quality health care in virtually every specialty and subspecialty, from primary care to cancer diagnosis and treatment to kidney and liver transplantation.
About Lung Cancer:
The most recent estimates indicate that over 240,000 new cases of respiratory system cancer will be diagnosed each year in the United States, and over 160,000 deaths each year. According to the American Cancer Society, lung cancer is by far the leading cause of cancer death among both men and women. In fact, more men die of lung cancer than of prostate cancer, and more women die of lung cancer than breast, uterine, and ovarian cancers combined. However, recent results from the National Lung Screening Trial showed that 20% fewer lung cancer deaths among current and former heavy smokers who were screened with low dose spiral CT compared to standard chest x-ray. More information on lung cancer can be found at www.cancer.org.
ActiViews is a privately held high-tech medical device company that develops, manufactures, and markets novel surgical navigation solutions. The company’s mission is to become the leading provider of simple, accurate, and affordable navigation solutions in order to enhance physician confidence in performing minimally invasive thoracic and abdominal surgical oncology procedures. The U.S. Patent and Trademark Office has approved the core technology platform patent with other ancillary patents currently pending. CT-Guide™ navigation is the first and only commercially available system for CT-guided interventions for both lung and liver applications. ActiViews, Inc. is located in the metro-Boston area with Research and Development facilities in Haifa, Israel. For further information visit the website at www.activiews.com. ActiViews, Navigate with Confidence™.